ethinyl estradiol has been researched along with Diabetes Mellitus, Type 2 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bettoni, L | 1 |
| Dimitrov, A; Kolarov, G; Mekhandzhiev, Ts; Nikolov, A; Todarova, K | 1 |
| Creatsas, G; Serfaty, D; Verougstraete, A; Wildemeersch, D | 1 |
| Andersen, LF; Christiansen, E; Jespersen, J; Madsbad, S; Petersen, KR; Skouby, SO | 1 |
| Diab, KM; Zaki, MM | 1 |
| Fotherby, K | 1 |
2 review(s) available for ethinyl estradiol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
[Contraception in women with diabetes mellitus].
Topics: Contraception; Contraceptive Devices; Contraceptives, Oral, Hormonal; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Ethinyl Estradiol; Family Planning Services; Female; Humans; Pregnancy; Pregnancy in Diabetics; Risk Factors | 2005 |
Oral contraceptives, lipids and cardiovascular disease.
Topics: Adult; Alcohol Drinking; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Desogestrel; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Ethinyl Estradiol; Female; Humans; Hyperlipidemias; Hyperthyroidism; Lipids; Norpregnenes; Obesity; Physical Exertion; Risk; Smoking | 1985 |
2 trial(s) available for ethinyl estradiol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives.
Topics: Adult; Antibodies, Monoclonal; Blood Glucose; C-Peptide; Cardiovascular Diseases; Contraceptives, Oral, Synthetic; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Ethinyl Estradiol; Female; Fibrinolysis; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Norgestrel; Plasminogen Activator Inhibitor 1; Prospective Studies; Tissue Plasminogen Activator; Triglycerides | 1999 |
Contraception in diabetic women: comparative metabolic study of Norplant, depot medroxyprogesterone acetate, low dose oral contraceptive pill and CuT380A.
Topics: Adult; Blood Coagulation; Blood Glucose; Blood Pressure; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Implants; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Lipoproteins; Medroxyprogesterone Acetate; Norpregnenes; Prospective Studies | 2000 |
2 other study(ies) available for ethinyl estradiol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Influence of ethinyl estradiol on C1s inhibitor: a new etiopathogenetic mechanism of angioedema. Case report.
Topics: Adult; Angioedema; Autoantibodies; Complement C1 Inactivator Proteins; Complement C1 Inhibitor Protein; Complement Inactivator Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dermatitis, Allergic Contact; Diabetes Mellitus, Type 2; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Serpins | 2005 |
European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Topics: Adult; Aging; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Data Collection; Desogestrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol Congeners; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progesterone Congeners; Risk Factors; Smoking; Surveys and Questionnaires | 1995 |